Windward Bio reports positive Phase 2 interim results for SKB378/WIN378
Windward Bio reported positive interim results from the Phase 2 portion of POLARIS-1, evaluating SKB378/WIN378 in asthma. Windward Bio has also initiated a Phase 3 study.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.